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Background

Cosmetic augmentation of the buttocks is a relatively
common procedure and may be performed utilizing
several techniques. A frequent method involves injecting
liquid silicone as a permanent filler directly into the
buttocks. Silicone is typically considered a benign, inert
substance, however localized integumentary reactions
are commonly reported adverse effects. Life-threatening
silicone-induced granulomatous reactions are rare.
We report a case of severe, recurrent hypercalcemia
secondary to silicone-induced granulomatous disease in
a female with a remote history of gluteal silicone injections.

Although silicone is typically considered
a benign and inert substance, it

may induce a localized granulomatous
reaction. This reaction may occur
years after the initial operation.
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Case Report

A 39-year-old female presented to the hospital
with weight loss, anorexia, weakness, nausea,
and vomiting. She stated symptoms have
been intermittent over the past several years.
Physical examination was remarkable for
cachectic appearance with a body mass
2
index of 13 kg/m as well as numerous large
palpable nodules and scarring to buttocks
and upper legs. She reported receiving
silicone injections for buttocks augmentation
twenty years earlier in the Dominican
Republic. Patient reported her silicone
injections had caused her similar symptoms
10 years ago and she underwent attempted
surgical excision of the associated
granulomas at that time. Review of symptoms
demonstrated progressive abdominal pain,
loss of appetite, and chronic buttock and
lower extremity pain. Family reported nonspecific personality changes in the patient.
Labs on admission were notable for
hemoglobin 8.4 g/dl, creatinine 2.1 mg/dl,

calcium 17.2 mg/dl (8.5-10.1), and ionized
calcium 1.89 mmol/L. The corrected calcium
was 18.7 mg/dL, accounting for an albumin of
2.3 g/dL. An MRI of the pelvis was obtained
and showed diffuse, extensive edema and
multiple foreign body granulomas within the
subcutaneous tissues of the pelvic wall/
gluteal region and proximal thighs. It was
determined the patient was experiencing
hypercalcemia from her silicone
granulomatous disease following an extensive,
multi-disciplinary team evaluation that ruled
out other potential etiologies. Hypercalcemia
was initially treated with intravenous fluids,
calcitonin, and corticosteroids. Patient elected
to have surgical excision of the granulomas
performed and pathology confirmed
siliconomas. Upon discharge the patient’s
calcium was 10.8 mg/dL. Patient has had
multiple subsequent admissions for continued
surgical excisions, reconstruction with skin
flaps, and wound infections.

Discussion

Silicone is utilized in multiple cosmetic enhancement
procedures. Silicone can be introduced directly in liquid
form (as in our case) or upon rupture of a silicone-filled
implant. Although silicone is typically considered a
benign and an inert substance, it may induce a
localized granulomatous reaction. The timeframe in
which this reaction occurs may be years after the initial
operation. Even when silicone-granulomatous reactions
occur, they are rarely associated with hypercalcemia.
The mechanism of silicone-induced hypercalcemia is
unknown and currently there is no consensus regarding
treatment. Standard hypercalcemia treatment including
intravenous hydration, calcitonin, bisphosphonates,
and corticosteroids has been utilized for silicone
granulomatous induced hypercalcemia. Surgical
excision of the siliconomas has also been described.

Conclusion

Severe hypercalcemia secondary to silicone granulomas
is a rare clinical entity and underreported in the
toxicology literature. It is an important consideration
when evaluating patients with cosmetic augmentations.
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